Kids can be prone to Infectious Diseases in early age. Parents should know well what to do to prevent kids from such Diseases.
Read more: https://thehealthjournal.co/infectious-diseases-in-kids-that-every-parent-should-know/
The global infectious disease diagnostics market was valued at USD 13.93 Billion in 2016 and projected to reach USD 19.35 Billion in 2022, at a CAGR of 5.6%.
The base year considered for the study is 2016, and the forecast for the market size is provided for the period between 2017 and 2022.
Growth in this market is primarily driven by the increasing global prevalence of infectious diseases, shift in focus from centralized laboratories to decentralized point-of-care testing, and growth in funding for research on infectious disease diagnosticsDownload PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=116764589Global Market Segmentation:The market is broadly segmented into assays, kits, & reagents; instruments; and services & software based on product & service.
The assays, kits, & reagents segment accounted for the largest share of the global market and is expected to register the highest CAGR during the forecast period.
The increasing number of infectious disease diagnostic tests carried out; easy accessibility to a wide range of reagents; and the growing need for reliable, specific, and faster detection of infectious diseases in the early stages are the key factors driving the IDD assays, kits, & reagents market.Based on the disease type, the market is segmented into hepatitis, HIV, HAIs, CT/NG, HPV, TB, Influenza, and other diseases.
The hepatitis diagnostics segment accounted for the largest share of the global market in 2017.
The global infectious diseases in vitro diagnostics market size is estimated to reach USD 33.1 billion by 2027, according to a new report by Radiant Insights, Inc., registering a CAGR of 6.3% over the forecast period.
Moreover, although most diagnostics are specific to an application, upcoming diagnostic products would be able to test and confirm multiple related diseases, thus saving time and money.
Download Free Sample Report @ https://www.radiantinsights.com/research/ivd-infectious-disease-market/request-sample Presence of various e-commerce sites offering diagnostic kits, especially Point of Care (PoC) devices, is expected to drive the sales of the products through this sales channel.
Moreover, the regulatory and reimbursement landscape is continually evolving to adapt to the fast-paced research progress in this sector.
Proactive initiatives by public and private organizations to raise consumer awareness about infectious diseases and treatment modalities are expected to drive the market growth in the coming years.
Further key findings from the report suggest: • Technological advancements related to accuracy, portability, and cost-effectiveness are expected to be high impact rendering drivers for the market • Growing awareness and increasing dependency of healthcare practitioners on the usage of point-of-care diagnostic enabled medical devices and consumables are expected to drive the IVD infectious diseases market growth over the forecast period • Key applications of immunochemistry include detection of infectious microorganisms such as virus, bacteria, and fungus and their toxins and coat antigens • Development of techniques such as Polymerase Chain Reaction (PCR) and in-situ hybridization is expected to boost the molecular diagnostics segment over the forecast period • Key players include bioMérieux SA; BD; Abbott; Quidel Corporation; F. Hoffmann-La Roche Ltd.; Alere Inc.; Cepheid; Hologic Inc.; Qiagen N.V.; Orasure Technologies, Inc.; Bio-Rad Laboratories, Inc.; and Siemens Healthcare GmbH.
